Medifron DBT Co., Ltd. (KOSDAQ:A065650) agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. (KOSDAQ:A214270) on April 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,190 KRW | +3.30% | -2.45% | -19.93% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,190 KRW | +3.30% | -2.45% | 53.36M | ||
1,443 KRW | -4.12% | -3.93% | 88.69M | ||
1st Jan change | Capi. | |
---|---|---|
-19.93% | 53.36M | |
+19.29% | 7.39B | |
-17.11% | 1.8B | |
-5.59% | 1.28B | |
-17.35% | 1.09B | |
+1.72% | 578M | |
-47.34% | 512M | |
-33.57% | 500M | |
+16.79% | 448M | |
-33.05% | 374M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..